Baxter International Inc. (NYSE: BAX) stock fell -1.85% on Thursday to $41.34 against a previous-day closing price of $42.12. With 3.86 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.86 million shares. During the session, the Medical Instruments & Supplies company that operates in wider Healthcare sector, reached to the highest price of $41.63 whereas the lowest price it dropped to was $41.00. The 52-week range on BAX shows that it touched its highest point at $77.08 and its lowest point at $37.35 during that stretch. It currently has a 1-year price target of $50.93. With its current market cap of 20.93 billion, BAX has annualized dividend of $1.16 while the current yield stands at 2.81%. Beta for the stock currently stands at 0.57.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BAX was down-trending over the past week, with a drop of -3.93%, but this was down by -10.29% over a month. Three-month performance surged to 2.94% while six-month performance fell -25.27%. The stock lost -44.06% in the past year, while it has lost -18.89% so far this year. A look at the trailing 12-month EPS for BAX yields -4.89 with Next year EPS estimates of 3.33. For the next quarter, that number is 0.61. This implies an EPS growth rate of -291.00% for this year and 13.48% for next year. EPS is expected to grow by 1.95% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -33.50%.
Float and Shares Shorts:
At present, 505.00 million BAX shares are outstanding with a float of 503.13 million shares on hand for trading. On Apr 27, 2023, short shares totaled 6.04 million, which was 1.19% higher than short shares on Mar 30, 2023. In addition to Mr. Jose E. Almeida as the firm’s Chairman, Pres & CEO, Mr. James K. Saccaro serves as its Exec. VP & CFO.
Through their ownership of 83.99% of BAX’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 6.64% of BAX, in contrast to 55.44% held by mutual funds. Shares owned by individuals account for 32.10%. As the largest shareholder in BAX with 11.59% of the stake, The Vanguard Group, Inc. holds 58,609,904 shares worth 58,609,904. A second-largest stockholder of BAX, BlackRock Fund Advisors, holds 27,610,959 shares, controlling over 5.46% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in BAX, holding 21,284,408 shares or 4.21% stake. With a 3.28% stake in BAX, the Vanguard Dividend Growth Fund is the largest stakeholder. A total of 16,576,448 shares are owned by the mutual fund manager. The Vanguard Total Stock Market ETF, which owns about 3.10% of BAX stock, is the second-largest Mutual Fund holder. It holds 15,678,343 shares valued at 747.54 million. Morgan Stanley Invt. Fds. – Globa holds 2.38% of the stake in BAX, owning 12,007,949 shares worth 572.54 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, BAX reported revenue of $3.75B and operating income of $340.00M. The EBITDA in the recently reported quarter was $720.00M and diluted EPS was $0.50.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BAX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With BAX analysts setting a high price target of $58.00 and a low target of $46.00, the average target price over the next 12 months is $50.64. Based on these targets, BAX could surge 40.3% to reach the target high and rise by 11.27% to reach the target low. Reaching the average price target will result in a growth of 22.5% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded BAX stock several times over the past three months with 24 Buys and 16 Sells. In these transactions, 292,246 shares were bought while 13,961 shares were sold. The number of buy transactions has increased to 35 while that of sell transactions has risen to 25 over the past year. The total number of shares bought during that period was 443,893 while 95,287 shares were sold.